- Home
- SDA vs AUPH Comparison
SDA vs AUPH Comparison
Compare SDA & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDA
- AUPH
- Stock Information
- Founded
- SDA 2007
- AUPH 1993
- Country
- SDA China
- AUPH Canada
- Employees
- SDA N/A
- AUPH N/A
- Industry
- SDA Blank Checks
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- SDA Finance
- AUPH Health Care
- Exchange
- SDA Nasdaq
- AUPH Nasdaq
- Market Cap
- SDA 969.0M
- AUPH 1.3B
- IPO Year
- SDA N/A
- AUPH 1999
- Fundamental
- Price
- SDA $9.01
- AUPH $8.77
- Analyst Decision
- SDA
- AUPH Strong Buy
- Analyst Count
- SDA 0
- AUPH 3
- Target Price
- SDA N/A
- AUPH $10.33
- AVG Volume (30 Days)
- SDA 346.9K
- AUPH 1.3M
- Earning Date
- SDA 09-16-2024
- AUPH 02-13-2025
- Dividend Yield
- SDA N/A
- AUPH N/A
- EPS Growth
- SDA N/A
- AUPH N/A
- EPS
- SDA N/A
- AUPH N/A
- Revenue
- SDA $407,454,000.00
- AUPH $220,361,000.00
- Revenue This Year
- SDA $26.41
- AUPH $36.97
- Revenue Next Year
- SDA N/A
- AUPH $16.43
- P/E Ratio
- SDA N/A
- AUPH N/A
- Revenue Growth
- SDA 28.51
- AUPH 38.72
- 52 Week Low
- SDA $5.71
- AUPH $4.71
- 52 Week High
- SDA $11.74
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- SDA 46.00
- AUPH 45.91
- Support Level
- SDA $9.07
- AUPH $8.89
- Resistance Level
- SDA $9.80
- AUPH $9.31
- Average True Range (ATR)
- SDA 0.64
- AUPH 0.34
- MACD
- SDA 0.07
- AUPH -0.11
- Stochastic Oscillator
- SDA 38.67
- AUPH 1.43
About SDA SunCar Technology Group Inc.
SunCar Technology Group Inc is a provider of digitalized enterprise automotive after-sales services and online auto insurance intermediation service in China. It operates an automotive after-sales services business through offering customized service solutions to enterprise clients, who are major banks, insurance companies, telecommunication companies, new energy vehicle, original equipment manufacturers or any client who have end customers demanding automotive services.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.